Mallolas J. et al.: Bictegravir/emtricitabine/tenofovir alafenamide (B/F/TAF) for the treatment of people living with HIV: 12-month effectiveness, persistence, and safety in a multi-country cohort study

Zurück zur Übersicht

27.-30.10.2021 / EACS